Chemokines and glioma: Invasion and more

Increasing pieces of evidence indicate that the chemokine system influences several aspects of brain physiology and pathology. A deregulated chemokine expression pattern is observed during neurological diseases, including multiple sclerosis and brain tumor. Gliomas are the most common primary tumors affecting human central nervous system (CNS). Chemokines expressed by stromal cells or endogenously produced by glioma cells may influence tumor cell migration, invasion, proliferation, angiogenesis and immune cell infiltration in the tumor mass. Herein we focus on chemokines and chemokine receptors expressed by glioma cells and their role in the regulation of glioma cell functional behaviour, including its ability to attract immune cells.

[1]  R. Bonavia,et al.  Stromal Cell-derived Factor 1α Stimulates Human Glioblastoma Cell Growth through the Activation of Both Extracellular Signal-regulated Kinases 1/2 and Akt , 2003 .

[2]  R. Prayson,et al.  The pathobiology of glioma tumors. , 2010, Annual review of pathology.

[3]  P. Allavena,et al.  Cancer-related inflammation , 2008, Nature.

[4]  J. Kuratsu,et al.  Quantitative study of monocyte chemoattractant protein-1 (MCP-1) in cerebrospinal fluid and cyst fluid from patients with malignant glioma. , 1993, Journal of the National Cancer Institute.

[5]  S. Coca,et al.  Presence and significance of NK cells in glioblastomas. , 1989, Journal of neurosurgery.

[6]  K. Matsushima,et al.  IL-1 and TNF-alpha induction of IL-8 and monocyte chemotactic and activating factor (MCAF) mRNA expression in a human astrocytoma cell line. , 1991, Immunology.

[7]  Alberto Mantovani,et al.  Tuning inflammation and immunity by chemokine sequestration: decoys and more , 2006, Nature Reviews Immunology.

[8]  Yan Zhou,et al.  The chemokine GRO-α (CXCL1) confers increased tumorigenicity to glioma cells , 2005 .

[9]  David J. Yang,et al.  The role of human glioma-infiltrating microglia/macrophages in mediating antitumor immune responses. , 2006, Neuro-oncology.

[10]  P. Allavena,et al.  Human glioma tumors express high levels of the chemokine receptor CX3CR1. , 2010, European cytokine network.

[11]  Y. Marie,et al.  Polymorphism in the microglial cell-mobilizing CX3CR1 gene is associated with survival in patients with glioblastoma. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[12]  G. Broggi,et al.  CXCL12 in Malignant Glial Tumors: A Possible Role in Angiogenesis and Cross-Talk between Endothelial and Tumoral Cells , 2004, Journal of Neuro-Oncology.

[13]  M. Tate,et al.  Biology of angiogenesis and invasion in glioma , 2009, Neurotherapeutics.

[14]  L. Chiriboga,et al.  Tumorigenesis and Neoplastic Progression Hypoxia-and Vascular Endothelial Growth Factor-Induced Stromal Cell-Derived Factor-1 / CXCR 4 Expression in Glioblastomas One Plausible Explanation of Scherer ’ s Structures , 2010 .

[15]  N. Warrington,et al.  Widespread CXCR4 activation in astrocytomas revealed by phospho-CXCR4-specific antibodies. , 2005, Cancer research.

[16]  L. Chin,et al.  Malignant astrocytic glioma: genetics, biology, and paths to treatment. , 2007, Genes & development.

[17]  P. Kabos,et al.  CXCR4 expression mediates glioma cell invasiveness , 2006, Oncogene.

[18]  G. Schettini,et al.  Expression of CXC chemokine receptors 1–5 and their ligands in human glioma tissues: Role of CXCR4 and SDF1 in glioma cell proliferation and migration , 2006, Neurochemistry International.

[19]  B. Scheithauer,et al.  The 2007 WHO classification of tumours of the central nervous system , 2007, Acta Neuropathologica.

[20]  M. Weller,et al.  The Innate Immune Response in the Central Nervous System and Its Role in Glioma Immune Surveillance , 2004, Oncology Research and Treatment.

[21]  Alexandra Kretz,et al.  Monocyte chemoattractant protein–1 increases microglial infiltration and aggressiveness of gliomas , 2003, Annals of neurology.

[22]  V. Wee Yong,et al.  CXCR4 Is a Major Chemokine Receptor on Glioma Cells and Mediates Their Survival* , 2002, The Journal of Biological Chemistry.

[23]  Andrew L Kung,et al.  A small-molecule antagonist of CXCR4 inhibits intracranial growth of primary brain tumors , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[24]  Hideki Matsumoto,et al.  Primary central nervous system lymphoma secretes monocyte chemoattractant protein 1 , 2007, Medical Molecular Morphology.

[25]  V. Yong,et al.  The chemokine stromal cell derived factor-1 (CXCL12) promotes glioma invasiveness through MT2-matrix metalloproteinase. , 2005, Carcinogenesis.

[26]  Ignacio A. Romero,et al.  Chemokine production and chemokine receptor expression by human glioma cells: Role of CXCL10 in tumour cell proliferation , 2008, Journal of Neuroimmunology.

[27]  E. Butcher,et al.  Chemokines in tissue-specific and microenvironment-specific lymphocyte homing. , 2000, Current opinion in immunology.

[28]  S. Leung,et al.  Monocyte chemoattractant protein-1 expression and macrophage infiltration in gliomas , 1997, Acta Neuropathologica.

[29]  Perez Hd,et al.  HIGH THROUGHPUT SCREENING FOR IDENTIFICATION OF RANTES CHEMOKINE EXPRESSION INHIBITORS , 1997 .

[30]  S. Dudas,et al.  Identification and localization of the cytokine SDF1 and its receptor, CXC chemokine receptor 4, to regions of necrosis and angiogenesis in human glioblastoma. , 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.

[31]  A. Zlotnik,et al.  The chemokine and chemokine receptor superfamilies and their molecular evolution , 2006, Genome Biology.

[32]  Chulhee Choi,et al.  CXC Chemokine Receptor 4 Expression and Function in Human Astroglioma Cells1 , 2001, The Journal of Immunology.

[33]  Erwin G. Van Meir,et al.  Human astrocytomas and glioblastomas express monocyte chemoattractant protein‐1 (MCP‐1) in vivo and in vitro , 1994, International journal of cancer.

[34]  M. Berens,et al.  Autocrine factors that sustain glioma invasion and paracrine biology in the brain microenvironment. , 2007, Journal of the National Cancer Institute.

[35]  M. Emi,et al.  Up-regulation of CC chemokine, CCL3L1, and receptors, CCR3, CCR5 in human glioblastoma that promotes cell growth , 2004, Journal of Neuro-Oncology.

[36]  H. Scherer.  Structural Development in Gliomas , 1938 .

[37]  D. Ribatti,et al.  Analysis of the role of chemokines in angiogenesis. , 2003, Journal of immunological methods.

[38]  L. Steinman,et al.  Neoplastic and reactive human astrocytes express interleukin-8 gene , 2004, Neurosurgical Review.

[39]  W. Broaddus,et al.  Membrane-type Matrix Metalloproteinases (MT-MMP)s: Expression and Function During Glioma Invasion , 2001, Journal of Neuro-Oncology.

[40]  M. Platten,et al.  Malignant glioma biology: Role for TGF‐β in growth, motility, angiogenesis, and immune escape , 2001 .

[41]  D. Long.  Capillary ultrastructure and the blood-brain barrier in human malignant brain tumors. , 1970, Journal of neurosurgery.

[42]  J. Kuratsu,et al.  Expression of lymphocyte-specific chemokines in human malignant glioma: Essential role of LARC in cellular immunity of malignant glioma. , 2002, International journal of oncology.

[43]  R. Maki,et al.  Characterization of fractalkine in rat brain cells: migratory and activation signals for CX3CR-1-expressing microglia. , 1999, Journal of immunology.

[44]  M. Esiri,et al.  Immunohistological study of mononuclear cell infiltrate in malignant gliomas , 2004, Acta Neuropathologica.

[45]  W. Streit,et al.  CX3CL1 and CX3CR1 in the GL261 murine model of glioma: CX3CR1 deficiency does not impact tumor growth or infiltration of microglia and lymphocytes , 2008, Journal of Neuroimmunology.

[46]  T. Iwama,et al.  Tumor-associated macrophage/microglia infiltration in human gliomas is correlated with MCP-3, but not MCP-1. , 2009, International journal of oncology.

[47]  D. Louis.  WHO classification of tumours of the central nervous system , 2007 .

[48]  Sujit S. Prabhu,et al.  Preferential migration of regulatory T cells mediated by glioma-secreted chemokines can be blocked with chemotherapy , 2007, Cancer Immunology, Immunotherapy.

[49]  R. Ravid,et al.  CX3CL1 and CX3CR1 Expression in Human Brain Tissue: Noninflammatory Control versus Multiple Sclerosis , 2003, Journal of neuropathology and experimental neurology.

[50]  F. Balkwill.  Cancer and the chemokine network , 2004, Nature Reviews Cancer.

[51]  C. Shun,et al.  Induced interleukin-8 expression in gliomas by tumor-associated macrophages , 2009, Journal of Neuro-Oncology.

[52]  R. Ransohoff,et al.  Chemokines and chemokine receptors in neurological disease: Raise, retain, or reduce? , 2007, Neurotherapeutics.

[53]  Erwin G. Van Meir,et al.  The role of interleukin-8 and its receptors in gliomagenesis and tumoral angiogenesis. , 2005, Neuro-oncology.

[54]  M. Weller,et al.  Irradiation and hypoxia promote homing of haematopoietic progenitor cells towards gliomas by TGF-β-dependent HIF-1α-mediated induction of CXCL12 , 2006 .

[55]  Christine E. Brown,et al.  Tumor-Derived Chemokine MCP-1/CCL2 Is Sufficient for Mediating Tumor Tropism of Adoptively Transferred T Cells1 , 2006, The Journal of Immunology.

[56]  W. Curry,et al.  Focus on TILs: Prognostic significance of tumor infiltrating lymphocytes in human glioma. , 2007, Cancer immunity.

[57]  Erwin G. Van Meir,et al.  Upregulation of Interleukin 8 by Oxygen-deprived Cells in Glioblastoma Suggests a Role in Leukocyte Activation, Chemotaxis, and Angiogenesis , 1997, The Journal of experimental medicine.

[58]  Michael Platten,et al.  Glioma Cell Invasion: Regulation of Metalloproteinase Activity by TGF-β , 2001, Journal of Neuro-Oncology.

[59]  A. Martin-Villalba,et al.  Sensing invasion: Cell surface receptors driving spreading of glioblastoma , 2010, Journal of cellular physiology.

[60]  R. Miller,et al.  Constitutive Expression of Growth-related Oncogene and Its Receptor in Oligodendrogliomas , 2001, Neurosurgery.

[61]  Francesca Aloisi,et al.  Chemokines and Glial Cells: A Complex Network in the Central Nervous System , 2004, Neurochemical Research.

[62]  G. Bernardini,et al.  CX3CR1/CX3CL1 axis negatively controls glioma cell invasion and is modulated by transforming growth factor-β1. , 2010, Neuro-oncology.

[63]  K. Reiss,et al.  Enhanced expression and shedding of the transmembrane chemokine CXCL16 by reactive astrocytes and glioma cells , 2005, Journal of neurochemistry.

[64]  J. Blay,et al.  Regulatory T cells recruited through CCL22/CCR4 are selectively activated in lymphoid infiltrates surrounding primary breast tumors and lead to an adverse clinical outcome. , 2009, Cancer research.

[65]  A. J. Valente,et al.  Post-translational modification of a monocyte-specific chemoattractant synthesized by glioma, osteosarcoma, and vascular smooth muscle cells. , 1990, The Journal of biological chemistry.

[66]  M. Adler,et al.  Viewing chemokines as a third major system of communication in the brain , 2005, The AAPS Journal.